Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127534621 | 12753462 | 1 | I | 20150316 | 20160725 | 20160915 | 20160915 | EXP | PHJP2016JP021566 | SANDOZ | INAZUMI K, SEKI R, YAMAUCHI A, KIMURA A, HASEGAWA T, IYO M. A CASE OF A LONG-PERIOD HOSPITALIZED PATIENT WHO WAS ALLOWED TO DISCHARGE AFTER RECONSIDERATION OF DIAGNOSIS IN OUR HOSPITAL. SEISHIN SHINKEIGAKU ZASSHI = PSYCHIATRIA ET NEUROLOGIA JAPONICA. 2016;S343 | 53.03 | YR | F | Y | 0.00000 | 20160915 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127534621 | 12753462 | 1 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | 400 MG, UNK | 0 | 400 | MG | TABLET | |||||||
| 127534621 | 12753462 | 2 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | 400-500 MG, UNK | 0 | 500 | MG | TABLET | |||||||
| 127534621 | 12753462 | 3 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 127534621 | 12753462 | 4 | SS | MEMANTINE. | MEMANTINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127534621 | 12753462 | 5 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | UNK | U | 78409 | |||||||||
| 127534621 | 12753462 | 6 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127534621 | 12753462 | 7 | SS | PALIPERIDONE. | PALIPERIDONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127534621 | 12753462 | 8 | C | LITHIUM. | LITHIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127534621 | 12753462 | 1 | Bipolar disorder |
| 127534621 | 12753462 | 4 | Bipolar disorder |
| 127534621 | 12753462 | 5 | Bipolar disorder |
| 127534621 | 12753462 | 6 | Bipolar disorder |
| 127534621 | 12753462 | 7 | Bipolar disorder |
| 127534621 | 12753462 | 8 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127534621 | 12753462 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127534621 | 12753462 | Altered state of consciousness | |
| 127534621 | 12753462 | Drug ineffective | |
| 127534621 | 12753462 | Pneumonia aspiration | |
| 127534621 | 12753462 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127534621 | 12753462 | 1 | 20130130 | 20160428 | 0 | |
| 127534621 | 12753462 | 3 | 20150408 | 20160428 | 0 |